ArticleNPJ breast cancer2021

Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer.

Laura M Spring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.